Category Archives: Prevention, Engagement and Care Cascade

The effects of intimate partner violence on women’s risk of HIV acquisition and engagement in the HIV treatment and care cascade: A pooled analysis of nationally representative surveys in sub-Saharan Africa

2023

Background Achieving the 95-95-95 targets for HIV diagnosis, treatment, and viral load suppression to end the HIV epidemic hinges on eliminating structural inequalities, including intimate partner violence (IPV). Sub-Saharan Africa...

Characterizing the impact of the COVID-19 pandemic on HIV PrEP care: A review and synthesis of the literature

2022

The global COVID-19 pandemic and associated lockdown measures have caused disruptions to sexual health services and created additional barriers to the continuity of HIV pre-exposure prophylaxis (PrEP) among key populations....

Educational technologies for HIV prevention in Black people: Scope review

2023

OBJECTIVE: To map the educational technologies implemented for HIV prevention in black people. METHOD: Scope review, performed according to the recommendations of The Joanna Briggs Institute, in Medline/PubMed, Embase, LILACS,...

Substance use and adherence to HIV pre-exposure prophylaxis in studies enrolling men who have sex with men and transgender women: A systematic review

2022

Optimal adherence to pre-exposure prophylaxis (PrEP) is critical, but challenging. Men who have sex with men and transgender women have high rates of HIV incidence and substance use. Substance use...

Factors associated with the involvement of women drug users in risky sexual behaviors: A narrative review

2022

BACKGROUND: Drug use is known as an important underlying factor in the occurrence of risky sexual behaviors. The present study was conducted to identify the factors associated with the involvement...

Does voluntary medical male circumcision reduce HIV risk in men who have sex with men?

2022

PURPOSE OF REVIEW: To review the evidence on the effect of voluntary medical male circumcision (VMMC) on reducing HIV risk among men who have sex with men (MSM) and assess...

Determinants of pre-exposure prophylaxis (PrEP) implementation in transgender populations: A qualitative scoping review

2022

We conducted a scoping review of contextual factors impeding uptake and adherence to pre-exposure prophylaxis in transgender communities as an in-depth analysis of the transgender population within a previously published...

Isoniazid preventive therapy for prevention of tuberculosis among people living with HIV in ethiopia: A systematic review of implementation and impacts

2023

BACKGROUND: Tuberculosis (TB) is a major cause of morbidity and mortality in people living with HIV (PLWHIV). Isoniazid preventive therapy (IPT) prevents TB in PLWHIV, but estimates of its effects...

Exploring the role of empowerment in Black women’s HIV and AIDS activism in the United States: An integrative literature review

2023

Black women in the United States continue to be disproportionately affected by the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) epidemic. HIV/AIDS activism among Black women for Black women may...

The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: A systematic review

2023

INTRODUCTION: The COVID-19 epidemic and various control and mitigation measures to combat the widespread outbreak of the disease may affect other parts of health care systems. There is a concern...

A review of factors associated with methadone maintenance treatment adherence and retention in Vietnam

2023

BACKGROUND: Starting in 2008, Vietnam’s national MMT program expanded quickly, but it is struggling with increasing attrition rates and poor adherence among patients. Several studies have reported on MMT retention...

Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis

2023

Introduction: Globally, hepatitis B virus (HBV) is a leading cause of liver disease. People who inject drugs (PWID) are at greater risk than the general population of contracting HBV. This risk...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!